Claims
- 1. A method of treating a vulnerable plaque associated with a blood vessel of a patient, the system comprising:
positioning an endoluminal device within a lumen of the blood vessel; expanding an expandable member of the endoluminal device adjacent a wall of the blood vessel;. administering a blood vessel coating substance from the expanded expandable member; and adhering the administered blood vessel coating substance to the wall of the blood vessel.
- 2. The method of claim 1 wherein administering the blood vessel coating substance comprises polymerizing said substance.
- 3. The method of claim 1 wherein the blood vessel coating substance comprises at least one substance selected from a group consisting of methyl cellulose, hydroxypropyl methyl cellulose, fibrinogen, thrombin, a glucose polymer, a polymer, a monomer, a cross-linking agent, a binding agent, a thickening agent, cellulose ether, an epoxy, a polyolefin, a polyethylene, a vinyl, a plastic, a polysaccharide, a biocompatible compound, a biodegradable compound, a heat sensitive compound, and Methocel™.
- 4. The system of claim 1 wherein the administered blood vessel coating substance comprises a film coating.
- 5. The method of claim 1 further comprising minimizing blood flow sheer forces exerted on the administered blood vessel coating substance.
- 6. The method of claim 1 further comprising administering at least one therapeutic agent to the patient wherein said agent provides a treatment benefit.
- 7. The method of claim 1 further comprising displacing the expandable member relative to the blood vessel.
- 8. The method of claim 1 further comprising capturing one or more emboli carried within the blood vessel.
- 9. A system for treating a vulnerable plaque associated with a blood vessel of a patient, the system comprising:
an endoluminal device including at least one aperture formed therein; and an expandable member operably attached to the endoluminal device, the expandable member comprising an outer surface including at least one groove disposed thereon; wherein the expandable member is expanded within the blood vessel and a blood vessel coating substance is administered through the aperture and onto the expandable member outer surface.
- 10. The system of claim 9 wherein the groove comprises a spiral configuration positioned around a circumference of the expandable member.
- 11. The system of claim 9 wherein the groove is adapted to minimize blood flow sheer forces exerted on the administered blood vessel coating substance.
- 12. The system of claim 9 wherein the blood vessel coating substance comprises a fluid that upon administration polymerizes into a solid or a semi-solid.
- 13. The system of claim 9 wherein the blood vessel coating substance comprises at least one substance selected from a group consisting of methyl cellulose, hydroxypropyl methyl cellulose, fibrinogen, thrombin, a glucose polymer, a polymer, a monomer, a cross-linking agent, a binding agent, a thickening agent, cellulose ether, an epoxy, a polyolefin, a polyethylene, a vinyl, a plastic, a polysaccharide, a biocompatible compound, a biodegradable compound, a heat sensitive compound, and Methocel™.
- 14. The system of claim 9 wherein the blood vessel coating substance adheres to a wall of the blood vessel.
- 15. The system of claim 9 wherein the administered blood vessel coating substance comprises a film coating.
- 16. The system of claim 9 further comprising at least one therapeutic agent adapted for administration to the patient wherein said agent provides a treatment benefit.
- 17. The system of claim 9 further comprising a movement apparatus adapted for displacing the expandable member relative to the blood vessel.
- 18. The system of claim 9 further comprising a capturing apparatus operably attached to the device adapted to capture one or more emboli carried within the blood vessel.
- 19. A system for treating a vulnerable plaque associated with a blood vessel of a patient, the system comprising:
means for positioning an endoluminal device within a lumen of the blood vessel; means for expanding an expandable member of the endoluminal device adjacent a wall of the blood vessel;. means for administering a blood vessel coating substance from the expanded expandable member; and means for adhering the administered blood vessel coating substance to the wall of the blood vessel.
- 20. The system of claim 19 further comprising means for minimizing blood flow sheer forces exerted on the administered blood vessel coating substance.
- 21. The system of claim 19 further comprising means for displacing the expandable member relative to the blood vessel.
- 22. The system of claim 19 further comprising means for capturing one or more emboli carried within the blood vessel.
RELATED APPLICATION
[0001] This application claims priority to U.S. Provisional Application No. 60/467,007, “Method and System for Treating Vulnerable Plaque” to Maura G. Donovan, filed Apr. 30, 2003, the entirety of which is incorporated by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60467007 |
Apr 2003 |
US |